Enova International, Inc.'s SEC filings document its online financial services business, public-company governance and financing arrangements used by lending subsidiaries. Recent 8-K reports cover operating results and amendments to receivables-backed facilities associated with OnDeck and NetCredit entities, including revolving loan commitments, note issuance arrangements and securitization facility terms.
Proxy materials describe board matters, shareholder voting items, executive compensation, equity awards and incentive-plan disclosures. Other material-event filings record management-transition compensation arrangements, capital-structure disclosures and obligations arising from amended credit facilities.
Enova International director-associated trust sells shares while direct holdings remain. On February 2, 2026, the Mark A Tebbe Revocable Trust, an entity associated with director Mark Tebbe, sold 20,000 shares of Enova International common stock at a weighted average price of $172.2412 per share.
These sales were executed in multiple trades at prices between $172.05 and $172.52. Following the reported transactions, Mark Tebbe directly beneficially owned 68,709 shares of Enova International common stock, separate from the trust’s now-disposed position.
Enova International director James A. Gray reported indirect sales of company stock through family trusts. On February 2, 2026, the JG 2002 Delta Trust sold 10,000 shares of Enova common stock at a weighted average price of $171.8632 per share. On the same date, the James Gray Revocable Trust sold 9,999 shares at a weighted average price of $172.2169 per share, leaving it holding 10,001 shares. Separately, Gray is shown as directly owning 68,709 shares of Enova common stock following these reported transactions.
Enova International CEO Steven E. Cunningham reported routine equity transactions. On January 30, 2026, he exercised a non-qualified stock option for 11,436 shares of common stock at an exercise price of $20.73 per share, increasing his direct holdings to 139,155 shares.
That same day, he sold 11,436 shares of Enova common stock in market transactions at a weighted average price of $165.1307 per share, leaving him with 127,719 shares directly owned after the sale. The option and a related stock appreciation right had been granted in tandem and fully vested by February 11, 2023.
Enova International’s General Counsel and Secretary, Sean Rahilly, reported an option exercise and share sale. On 01/30/2026, he exercised 12,879 non-qualified stock options at an exercise price of $20.73 per share, receiving 12,879 common shares.
That same day, he sold 12,879 common shares at a weighted average price of $164.2821, from multiple trades between $163.415 and $164.95. After these transactions, he directly held 100,877 shares of common stock and 15,000 non-qualified stock options.
Enova International Executive Chairman David Fisher reported exercising stock options and selling shares of the company’s common stock. On January 30, 2026, he exercised a non-qualified stock option for 37,989 shares of Enova common stock at an exercise price of $23.96 per share.
On the same day, he sold 37,989 shares of Enova common stock at a weighted average price of $165.315 per share, with individual trade prices ranging from $163.885 to $166.73. Following these transactions, Fisher directly held 348,223 shares of Enova common stock. The option for 37,989 shares, which vested in three annual installments from February 2020 through February 2022, was fully exercised and no longer outstanding.
Enova International investor David Fisher filed a Form 144/A notice to sell 37,989 shares of Enova common stock through Merrill Lynch on the NYSE around 01/30/2026, with an aggregate market value of 6,268,185.
The shares to be sold were acquired on 02/12/2019 via a stock option transaction with Enova International. Over the prior three months, Fisher reported four sales of Enova common stock totaling 36,573 shares, with disclosed gross proceeds for each transaction.
An insider of Enova International filed a notice to sell 14,452 common shares through broker Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $2,386,828.69 and an approximate sale date of 01/30/2026.
The shares come from 3,016 restricted stock shares acquired on 02/08/2024 and 11,436 shares obtained via a cash stock option exercise on 01/30/2026. The filer also represents that they are not aware of undisclosed material adverse information about Enova’s current or prospective operations.
Enova International filed a Form 144 notice for a planned insider sale of common stock. The filing covers 12,879 common shares to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 2,115,789.17 and 24,801,579 shares outstanding.
The 12,879 shares were acquired on 01/30/2026 via a stock option exercise from the issuer, paid in cash, with the approximate sale date also listed as 01/30/2026.
Enova International insider David Fisher has filed a Rule 144 notice to sell 37,989 shares of Enova common stock. The planned sale is to be executed through Merrill Lynch on the NYSE, with an approximate sale date of January 26, 2026.
The filing also lists prior sales over the past three months: 6,000 shares on October 27, 2025, 6,000 shares on November 21, 2025, 15,000 shares on December 16, 2025, and 9,573 shares on January 26, 2026, all in Enova common stock.
Enova International Executive Chairman David Fisher reported an option exercise and share sale. On January 26, 2026, he exercised a non-qualified stock option for 9,573 shares of common stock at an exercise price of $23.96 per share. The same day, he sold 9,573 shares of common stock at a weighted average price of $157.805 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, Fisher directly held 348,223 shares of Enova common stock and 37,989 derivative securities (stock options) linked to common shares.